Jazz Pharmaceuticals (JAZZ) Change in Cash (2010 - 2026)

Jazz Pharmaceuticals' Change in Cash history runs 17 years deep, the most recent figure standing at $452.4 million for Q1 2026.

• In Q1 2026, Change in Cash rose 182.11% year-over-year to $452.4 million; the TTM figure through Mar 2026 stood at -$17.6 million (down 104.2% YoY), while the FY2025 annual figure was -$1.0 billion, down 212.62% from the prior year.
• Change in Cash for Q1 2026 stood at $452.4 million, up from $65.8 million in the prior quarter.
• The five-year high for Change in Cash was $862.3 million in Q3 2024, with the low at -$672.0 million in Q2 2025.
• The 5-year median for Change in Cash is $114.4 million (2023), against an average of $73.7 million.
• The sharpest annual moves came in 2024 and 2025: Change in Cash soared 1515.28% in 2024, then plunged 775.65% in 2025.
• Jazz Pharmaceuticals' Change in Cash stood at $42.1 million in 2022, then jumped by 305.04% to $170.6 million in 2023, then grew by 14.13% to $194.7 million in 2024, then slumped by 66.19% to $65.8 million in 2025, then jumped by 587.24% to $452.4 million in 2026.
• Business Quant data shows JAZZ's Change in Cash at $452.4 million in Q1 2026, $65.8 million in Q4 2025, and $136.2 million in Q3 2025.